Light Mode
$0.6220 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.6220, $0.0365 below the day’s high of $0.6585
-0.89 (-58.81%) / 6M
Momentum, market sentiment, and recent alerts
FLNA reads poor: the 12-month move is -70.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.